A Study to Evaluate the Efficacy of the Nasal Antiseptic, PrevinC, When Administered for the RiskReduction of Rhinitis in Subjects Who Work for Child Day Care Centers
| Status: | Completed |
|---|---|
| Conditions: | Pulmonary |
| Therapuetic Areas: | Pulmonary / Respiratory Diseases |
| Healthy: | No |
| Age Range: | 18 - 65 |
| Updated: | 1/18/2019 |
| Start Date: | February 2005 |
| End Date: | May 2005 |
The hypothesis was to establish whether the use of PrevinC administered nasally 2-3 times a
day will prevent upper respiratory infections in otherwise healthy adults working in child
day care centers.
day will prevent upper respiratory infections in otherwise healthy adults working in child
day care centers.
Inclusion Criteria:
- Subject must provide written informed consent prior to the conduct of any study
- Male or female
- 18-65 years of age
- Inclusive
- Employed by one of seven selected Day Care Centers
Exclusion Criteria:
- Recent symptoms of upper respiratory infection, respiratory disease
- Received medication for colds or allergies within 3 weeks of enrolling
- Had nasal surgery within 2 months of enrolling
- Had a pierced nose or wore nose jewelry
We found this trial at
5
sites
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials